{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T14:17:39Z","timestamp":1769005059804,"version":"3.49.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["TUBITAK-1004-18AG020"],"award-info":[{"award-number":["TUBITAK-1004-18AG020"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s12033-022-00616-8","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T19:11:27Z","timestamp":1669835487000},"page":"1129-1139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Incubation Temperature and Period During Denarase Treatment and Microfiltration Affect the Yield of Recombinant Adenoviral Vectors During Downstream Processing"],"prefix":"10.1007","volume":"65","author":[{"given":"Fatma Gizem","family":"Sonug\u00fcr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cansu","family":"Babahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Abdi Abgarmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1631-5739","authenticated-orcid":false,"given":"Hakan","family":"Akbulut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,30]]},"reference":[{"key":"616_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/sj.gt.3302624","volume":"12","author":"R Morenweiser","year":"2005","unstructured":"Morenweiser, R. (2005). Downstream processing of viral vectors and vaccines. Gene Therapy, 12, 103\u2013110.","journal-title":"Gene Therapy"},{"key":"616_CR2","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1134\/S0006297916070063","volume":"81","author":"A Lukashev","year":"2016","unstructured":"Lukashev, A., & Zamyatnin, A. (2016). Viral vectors for gene therapy: Current state and clinical perspectives. Biochemistry (Moscow), 81, 700\u2013708.","journal-title":"Biochemistry (Moscow)"},{"key":"616_CR3","doi-asserted-by":"crossref","unstructured":"Mendon\u00e7a, S.A., Lorincz, R., Boucher, P., & Curiel, D.T. (2021) Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic. npj Vaccines 6, 97.","DOI":"10.1038\/s41541-021-00356-x"},{"key":"616_CR4","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.4049\/jimmunol.181.3.2134","volume":"181","author":"DM Appledorn","year":"2008","unstructured":"Appledorn, D. M., Patial, S., McBride, A., Godbehere, S., Van Rooijen, N., Parameswaran, N., & Amalfitano, A. (2008). Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo. Journal of Immunology, 181, 2134\u20132144.","journal-title":"Journal of Immunology"},{"key":"616_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1556\/EuJMI.1.2011.4.3","volume":"1","author":"G Fejer","year":"2011","unstructured":"Fejer, G., Freudenberg, M., Greber, U. F., & Gyory, I. (2011). Adenovirus-triggered innate signalling pathways. European Journal of Microbiology and Immunology (Bp), 1, 279\u2013288.","journal-title":"European Journal of Microbiology and Immunology (Bp)"},{"key":"616_CR6","doi-asserted-by":"publisher","first-page":"9590","DOI":"10.1128\/JVI.00740-12","volume":"86","author":"JE Teigler","year":"2012","unstructured":"Teigler, J. E., Iampietro, M. J., & Barouch, D. H. (2012). Vaccination with adenovirus serotypes 35, 26, and 48 elicits higher levels of innate cytokine responses than adenovirus serotype 5 in rhesus monkeys. Journal of Virology, 86, 9590\u20139598.","journal-title":"Journal of Virology"},{"key":"616_CR7","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S0140-6736(20)31866-3","volume":"396","author":"DY Logunov","year":"2020","unstructured":"Logunov, D. Y., Dolzhikova, I. V., Zubkova, O. V., Tukhvatulin, A. I., Shcheblyakov, D. V., Dzharullaeva, A. S., Grousova, D. M., Erokhova, A. S., Kovyrshina, A. V., Botikov, A. G., Izhaeva, F. M., Popova, O., Ozharovskaya, T. A., Esmagambetov, I. B., Favorskaya, I. A., Zrelkin, D. I., Voronina, D. V., Shcherbinin, D. N., Semikhin, A. S., et al. (2020). Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: Two open, non-randomised phase 1\/2 studies from Russia. The Lancet, 396, 887\u2013897.","journal-title":"The Lancet"},{"key":"616_CR8","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.3324\/haematol.2021.279289","volume":"106","author":"P Gresele","year":"2021","unstructured":"Gresele, P., Momi, S., Marcucci, R., Ramundo, F., De Stefano, V., & Tripodi, A. (2021). Interactions of adenoviruses with platelets and coagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome. Haematologica, 106, 3034\u20133045.","journal-title":"Haematologica"},{"key":"616_CR9","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1016\/j.ymthe.2020.10.002","volume":"28","author":"EJ Kremer","year":"2020","unstructured":"Kremer, E. J. (2020). Pros and cons of adenovirus-based SARS-CoV-2 vaccines. Molecular Therapy, 28, 2303\u20132304.","journal-title":"Molecular Therapy"},{"key":"616_CR10","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3390\/vaccines8040574","volume":"8","author":"EE Sayedahmed","year":"2020","unstructured":"Sayedahmed, E. E., Elkashif, A., Alhashimi, M., Sambhara, S., & Mittal, S. K. (2020). Adenoviral vector-based vaccine platforms for developing the next generation of influenza vaccines. Vaccines, 8, 574.","journal-title":"Vaccines"},{"key":"616_CR11","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.3390\/v2081681","volume":"2","author":"I Kovesdi","year":"2010","unstructured":"Kovesdi, I., & Hedley, S. J. (2010). Adenoviral producer cells. Viruses, 2, 1681\u20131703.","journal-title":"Viruses"},{"issue":"12","key":"616_CR12","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/S1473-3099(21)00396-0","volume":"21","author":"S Wu","year":"2021","unstructured":"Wu, S., Huang, J., Zhang, Z., Wu, J., Zhang, J., Hu, H., Zhu, T., Zhang, J., Luo, L., Fan, P., Wang, B., Chen, C., Chen, Y., Song, X., Wang, Y., Si, W., Sun, T., Wang, X., Hou, L., et al. (2021). Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial. The Lancet Infectious Diseases, 21(12), 1654\u20131664.","journal-title":"The Lancet Infectious Diseases"},{"key":"616_CR13","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3390\/cancers12051139","volume":"12","author":"J Gao","year":"2020","unstructured":"Gao, J., Zhang, W., & Ehrhardt, A. (2020). Expanding the spectrum of adenoviral vectors for cancer therapy. Cancers, 12, 1139.","journal-title":"Cancers"},{"key":"616_CR14","doi-asserted-by":"publisher","first-page":"100432","DOI":"10.1016\/j.dmpk.2021.100432","volume":"42","author":"F Sakurai","year":"2021","unstructured":"Sakurai, F., Tachibana, M., & Mizuguchi, H. (2021). Adenovirus vector-based vaccine for infectious diseases. Drug Metabolism and Pharmacokinetics, 42, 100432.","journal-title":"Drug Metabolism and Pharmacokinetics"},{"key":"616_CR15","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/sj.cgt.7700536","volume":"9","author":"M Wisher","year":"2002","unstructured":"Wisher, M. (2002). Biosafety and product release testing issues relevant to replication-competent oncolytic viruses. Cancer Gene Therapy, 9, 1056\u20131061.","journal-title":"Cancer Gene Therapy"},{"key":"616_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41541-021-00292-w","volume":"6","author":"NC Kyriakidis","year":"2021","unstructured":"Kyriakidis, N. C., L\u00f3pez-Cort\u00e9s, A., Gonz\u00e1lez, E. V., Grimaldos, A. B., & Prado, E. O. (2021). SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates. npj Vaccines, 6, 28.","journal-title":"npj Vaccines"},{"key":"616_CR17","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","volume":"395","author":"F-C Zhu","year":"2020","unstructured":"Zhu, F.-C., Li, Y.-H., Guan, X.-H., Hou, L.-H., Wang, W.-J., Li, J.-X., Wu, S.-P., Wang, B.-S., Wang, Z., & Wang, L. (2020). Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: A dose-escalation, open-label, non-randomised, first-in-human trial. The Lancet, 395, 1845\u20131854.","journal-title":"The Lancet"},{"key":"616_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00203-021-02606-x","volume":"204","author":"AV Hebbani","year":"2022","unstructured":"Hebbani, A. V., Pulakuntla, S., Pannuru, P., Aramgam, S., Badri, K. R., & Reddy, V. D. (2022). COVID-19: Comprehensive review on mutations and current vaccines. Archives of Microbiology, 204, 1\u201317.","journal-title":"Archives of Microbiology"},{"key":"616_CR19","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3390\/ijms20030621","volume":"20","author":"L Kuryk","year":"2019","unstructured":"Kuryk, L., M\u00f8ller, A.-S.W., Vuolanto, A., Pesonen, S., Garofalo, M., Cerullo, V., & Jaderberg, M. (2019). Optimization of early steps in oncolytic adenovirus ONCOS-401 production in T-175 and HYPERFlasks. International Journal of Molecular Sciences, 20, 621.","journal-title":"International Journal of Molecular Sciences"},{"key":"616_CR20","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1016\/j.xphs.2021.03.024","volume":"110","author":"A Srivastava","year":"2021","unstructured":"Srivastava, A., Mallela, K. M. G., Deorkar, N., & Brophy, G. (2021). Manufacturing challenges and rational formulation development for AAV viral vectors. Journal of Pharmaceutical Sciences, 110, 2609\u20132624.","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"616_CR21","doi-asserted-by":"publisher","first-page":"1900411","DOI":"10.1002\/biot.201900411","volume":"15","author":"AS Moreira","year":"2020","unstructured":"Moreira, A. S., Silva, A. C., Sousa, M. F., Hagner-McWhirterc, \u00c5., Ahl\u00e9nc, G., Lundgren, M., Coroadinha, A. S., Alves, P. M., Peixoto, C., & Carrondo, M. J. (2020). Establishing suspension cell cultures for improved manufacturing of oncolytic adenovirus. Biotechnology Journal, 15, 1900411.","journal-title":"Biotechnology Journal"},{"key":"616_CR22","doi-asserted-by":"publisher","first-page":"366","DOI":"10.2174\/1566523218666181109141257","volume":"18","author":"MG Moleirinho","year":"2018","unstructured":"Moleirinho, M. G., Rosa, S., Carrondo, M. J., Silva, R. J., Hagner-McWhirter, \u00c5., Ahl\u00e9n, G., Lundgren, M., Alves, P. M., & Peixoto, C. (2018). Clinical-grade Oncolytic adenovirus purification using polysorbate 20 as an alternative for cell Lysis. Current Gene Therapy, 18, 366\u2013374.","journal-title":"Current Gene Therapy"},{"key":"616_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jcv.2016.11.009","volume":"86","author":"F Colavita","year":"2017","unstructured":"Colavita, F., Quartu, S., Lalle, E., Bordi, L., Lapa, D., Meschi, S., Vulcano, A., Toffoletti, A., Bordi, E., Paglia, M. G., Di Caro, A., Ippolito, G., Capobianchi, M. R., & Castilletti, C. (2017). Evaluation of the inactivation effect of Triton X-100 on Ebola virus infectivity. Journal of Clinical Virology, 86, 27\u201330.","journal-title":"Journal of Clinical Virology"},{"key":"616_CR24","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1002\/btpr.1824","volume":"29","author":"M Lei","year":"2013","unstructured":"Lei, M., Hewitt, D., Cornell, C., Skidmore, K., Kao, Y. H., Sugahara, J., Beane, D., & Ji, J. (2013). The effects of membrane filters used in biopharmaceutical processes on the concentration and composition of polysorbate 20. Biotechnology Progress, 29, 1503\u20131511.","journal-title":"Biotechnology Progress"},{"key":"616_CR25","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1021\/bp049644r","volume":"21","author":"JO Konz","year":"2005","unstructured":"Konz, J. O., Lee, A. L., Lewis, J. A., & Sagar, S. L. (2005). Development of a purification process for adenovirus: Controlling virus aggregation to improve the clearance of host cell DNA. Biotechnology Progress, 21, 466\u2013472.","journal-title":"Biotechnology Progress"},{"key":"616_CR26","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/jgm.1383","volume":"11","author":"MN Eglon","year":"2009","unstructured":"Eglon, M. N., Duffy, A. M., O\u2019Brien, T., & Strappe, P. M. (2009). Purification of adenoviral vectors by combined anion exchange and gel filtration chromatography. The Journal of Gene Medicine, 11, 978\u2013989.","journal-title":"The Journal of Gene Medicine"},{"key":"616_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-1-62703-679-5_14","volume":"1089","author":"M Puig","year":"2014","unstructured":"Puig, M., Piedra, J., Miravet, S., & Segura, M. M. (2014). Canine adenovirus downstream processing protocol. Methods in Molecular Biology (Clifton, NJ), 1089, 197\u2013210.","journal-title":"Methods in Molecular Biology (Clifton, NJ)"},{"key":"616_CR28","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1002\/bit.27472","volume":"117","author":"B Adams","year":"2020","unstructured":"Adams, B., Bak, H., & Tustian, A. D. (2020). Moving from the bench towards a large scale, industrial platform process for adeno-associated viral vector purification. Biotechnology and Bioengineering, 117, 3199\u20133211.","journal-title":"Biotechnology and Bioengineering"},{"key":"616_CR29","doi-asserted-by":"publisher","first-page":"6951","DOI":"10.1016\/j.vaccine.2019.04.056","volume":"37","author":"S Fedosyuk","year":"2019","unstructured":"Fedosyuk, S., Merritt, T., Peralta-Alvarez, M. P., Morris, S. J., Lam, A., Laroudie, N., Kangokar, A., Wright, D., Warimwe, G. M., Angell-Manning, P., Ritchie, A. J., Gilbert, S. C., Xenopoulos, A., Boumlic, A., & Douglas, A. D. (2019). Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact components. Vaccine, 37, 6951\u20136961.","journal-title":"Vaccine"},{"key":"616_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biotechadv.2015.11.005","volume":"34","author":"L Besnard","year":"2016","unstructured":"Besnard, L., Fabre, V., Fettig, M., Gousseinov, E., Kawakami, Y., Laroudie, N., Scanlan, C., & Pattnaik, P. (2016). Clarification of vaccines: An overview of filter based technology trends and best practices. Biotechnology Advances, 34, 1\u201313.","journal-title":"Biotechnology Advances"},{"key":"616_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jbiotec.2020.12.004","volume":"326","author":"JJ Labisch","year":"2021","unstructured":"Labisch, J. J., Bollmann, F., Wolff, M. W., & Pflanz, K. (2021). A new simplified clarification approach for lentiviral vectors using diatomaceous earth improves throughput and safe handling. Journal of Biotechnology, 326, 11\u201320.","journal-title":"Journal of Biotechnology"},{"key":"616_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.omtm.2019.11.011","volume":"17","author":"M Bauler","year":"2020","unstructured":"Bauler, M., Roberts, J. K., Wu, C. C., Fan, B., Ferrara, F., Yip, B. H., Diao, S., Kim, Y. I., Moore, J., Zhou, S., Wielgosz, M. M., Ryu, B., & Throm, R. E. (2020). Production of lentiviral vectors using suspension cells grown in serum-free media. Molecular Therapy\u2014Methods & Clinical Development, 17, 58\u201368.","journal-title":"Molecular Therapy\u2014Methods & Clinical Development"},{"key":"616_CR33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.12665\/J111.Raghunath","volume":"11","author":"BV Raghunath","year":"2012","unstructured":"Raghunath, B. V., Bin, W., Pattnaik, P., & Janssens, J. H. (2012). Best practices for optimization and scale-up of microfiltration TFF processes. BioProcessing Journal, 11, 30\u201340.","journal-title":"BioProcessing Journal"},{"key":"616_CR34","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/10_008","volume":"99","author":"NE Altaras","year":"2005","unstructured":"Altaras, N. E., Aunins, J. G., Evans, R. K., Kamen, A., Konz, J. O., & Wolf, J. J. (2005). Production and formulation of adenovirus vectors. Advances in Biochemical Engineering\/Biotechnology, 99, 193\u2013260.","journal-title":"Advances in Biochemical Engineering\/Biotechnology"},{"key":"616_CR35","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11157-017-9434-1","volume":"16","author":"GA Junter","year":"2017","unstructured":"Junter, G. A., & Lebrun, L. (2017). Cellulose-based virus-retentive filters: A review. Re\/Views in Environmental Science and Bio\/Technology, 16, 455\u2013489.","journal-title":"Re\/Views in Environmental Science and Bio\/Technology"},{"key":"616_CR36","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.omtm.2022.06.007","volume":"26","author":"S Kuroda","year":"2022","unstructured":"Kuroda, S., Miyagawa, Y., Sukegawa, M., Tomono, T., Yamamoto, M., Adachi, K., Verlengia, G., Goins, W. F., Cohen, J. B., & Glorioso, J. C. (2022). Evaluation of parameters for efficient purification and long-term storage of herpes simplex virus-based vectors. Molecular Therapy Methods & Clinical Development, 26, 132\u2013143.","journal-title":"Molecular Therapy Methods & Clinical Development"},{"key":"616_CR37","doi-asserted-by":"crossref","unstructured":"Shabram, P., Vellekamp, G., & Scandella, C. (2002) Purification of adenovirus, adenoviral vectors for gene therapy. In: Purification of adenovirus (pp. 167\u2013203). San Diego.","DOI":"10.1016\/B978-012199504-1\/50008-0"},{"key":"616_CR38","doi-asserted-by":"publisher","first-page":"15024","DOI":"10.1038\/mtm.2015.24","volume":"2","author":"G Dias Florencio","year":"2015","unstructured":"Dias Florencio, G., Precigout, G., Beley, C., Buclez, P. O., Garcia, L., & Benchaouir, R. (2015). Simple downstream process based on detergent treatment improves yield and in vivo transduction efficacy of adeno-associated virus vectors. Molecular Therapy\u2014Methods & Clinical Development, 2, 15024.","journal-title":"Molecular Therapy\u2014Methods & Clinical Development"},{"key":"616_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115802","volume":"9","author":"P Nestola","year":"2014","unstructured":"Nestola, P., Martins, D. L., Peixoto, C., Roederstein, S., Schleuss, T., Alves, P. M., Mota, J. P., & Carrondo, M. J. (2014). Evaluation of novel large cut-off ultrafiltration membranes for adenovirus serotype 5 (Ad5) concentration. PLoS ONE, 9, e115802.","journal-title":"PLoS ONE"},{"key":"616_CR40","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3390\/v13030388","volume":"13","author":"S Kulanayake","year":"2021","unstructured":"Kulanayake, S., & Tikoo, S. K. (2021). Adenovirus core proteins: Structure and function. Viruses, 13, 388.","journal-title":"Viruses"},{"key":"616_CR41","doi-asserted-by":"publisher","first-page":"5553","DOI":"10.1038\/s41467-021-25796-w","volume":"12","author":"B Meyer","year":"2021","unstructured":"Meyer, B., Chiaravalli, J., Gellenoncourt, S., Brownridge, P., Bryne, D. P., Daly, L. A., Grauslys, A., Walter, M., Agou, F., Chakrabarti, L. A., Craik, C. S., Eyers, C. E., Eyers, P. A., Gambin, Y., Jones, A. R., Sierecki, E., Verdin, E., Vignuzzi, M., & Emmott, E. (2021). Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential. Nature Communications, 12, 5553.","journal-title":"Nature Communications"},{"key":"616_CR42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000111480","volume":"35","author":"J Bl\u00fcmel","year":"2008","unstructured":"Bl\u00fcmel, J., Burger, R., Drosten, C., Gr\u00f6ner, A., G\u00fcrtler, L., Heiden, M., Hildebrandt, M., Jansen, B., Klamm, H., Montag-Lessing, T., Offergeld, R., Pauli, G., Seitz, R., Schlenkrich, U., Schottstedt, V., Willkommen, H., & von K\u00f6nig, C. H. (2008). Influenza virus. Transfusion Medicine and Hemotherapy, 35, 42\u201349.","journal-title":"Transfusion Medicine and Hemotherapy"},{"key":"616_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.coche.2021.100780","volume":"35","author":"N Singh","year":"2022","unstructured":"Singh, N., & Heldt, C. L. (2022). Challenges in downstream purification of gene therapy viral vectors. Current Opinion in Chemical Engineering, 35, 100780.","journal-title":"Current Opinion in Chemical Engineering"},{"key":"616_CR44","unstructured":"National Library of Medicine (U.S.).Phase I Randomized Double-Blind Clinical Trial With New SARS-CoV-2 CoVacHGMix Type 5 Adenoviral Vector Vaccine in Healthy Volunteers Aged 18\u201345 Years (January 21, 2022), Identifier: NCT05526183."},{"key":"616_CR45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.omtm.2020.08.013","volume":"19","author":"J Ma","year":"2020","unstructured":"Ma, J., Su, C., Hu, S., Chen, Y., Shu, Y., Yue, D., Zhang, B., Qi, Z., Li, S., Wang, X., Kuang, Y., & Cheng, P. (2020). The Effect of Residual Triton X-100 on Structural Stability and Infection Activity of Adenovirus Particles. Molecular Therapy\u2014Methods & Clinical Development, 19, 35\u201346.","journal-title":"Molecular Therapy\u2014Methods & Clinical Development"},{"key":"616_CR46","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1089\/hum.2014.007","volume":"25","author":"J Vellinga","year":"2014","unstructured":"Vellinga, J., Smith, J. P., Lipiec, A., Majhen, D., Lemckert, A., van Ooij, M., Ives, P., Yallop, C., Custers, J., & Havenga, M. (2014). Challenges in manufacturing adenoviral vectors for global vaccine product deployment. Human Gene Therapy, 25, 318\u2013327.","journal-title":"Human Gene Therapy"},{"key":"616_CR47","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/bit.27945","volume":"119","author":"CC Joe","year":"2022","unstructured":"Joe, C. C., Jiang, J., Linke, T., Li, Y., Fedosyuk, S., Gupta, G., Berg, A., Segireddy, R. R., Mainwaring, D., & Joshi, A. (2022). Manufacturing a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine to meet global needs. Biotechnology and Bioengineering, 119, 48.","journal-title":"Biotechnology and Bioengineering"},{"key":"616_CR48","volume-title":"Improving downstream processing for viral vectors and viral vaccines","author":"P Nestola","year":"2015","unstructured":"Nestola, P. (2015). Improving downstream processing for viral vectors and viral vaccines. Universidade NOVA de Lisboa Portugal."},{"key":"616_CR49","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1586\/erv.11.111","volume":"10","author":"MW Wolf","year":"2011","unstructured":"Wolf, M. W., & Reichl, U. (2011). Downstream processing of cell culture-derived virus particles. Expert Review of Vaccines, 10, 1451\u20131475.","journal-title":"Expert Review of Vaccines"},{"key":"616_CR50","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ab.2009.08.044","volume":"396","author":"MQT Tran","year":"2010","unstructured":"Tran, M. Q. T., Nygren, Y., Lundin, C., Naredi, P., & Bj\u00f6rn, E. (2010). Evaluation of cell lysis methods for platinum metallomic studies of human malignant cells. Analytical Biochemistry, 396, 76\u201382.","journal-title":"Analytical Biochemistry"},{"key":"616_CR51","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1173","volume":"47","author":"B Dura","year":"2018","unstructured":"Dura, B., Choi, J.-Y., Zhang, K., Damsky, W., Thakral, D., Bosenberg, M., Craft, J., & Fan, R. (2018). scFTD-seq: Freeze-thaw lysis based, portable approach toward highly distributed single-cell 3\u2032 mRNA profiling. Nucleic Acids Research, 47, e16.","journal-title":"Nucleic Acids Research"},{"key":"616_CR52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.omtm.2020.08.013","volume":"19","author":"J Ma","year":"2020","unstructured":"Ma, J., Su, C., Hu, S., Chen, Y., Shu, Y., Yue, D., Zhang, B., Qi, Z., Li, S., & Wang, X. (2020). The effect of residual Triton X-100 on structural stability and infection activity of adenovirus PARTICLES. Molecular Therapy\u2014Methods & Clinical Development, 19, 35\u201346.","journal-title":"Molecular Therapy\u2014Methods & Clinical Development"},{"key":"616_CR53","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/mtm.2016.18","volume":"3","author":"G Ungerechts","year":"2016","unstructured":"Ungerechts, G., Bossow, S., Leuchs, B., Holm, P. S., Rommelaere, J., Coffey, M., Coffin, R., Bell, J., & Nettelbeck, D. M. (2016). Moving oncolytic viruses into the clinic: Clinical-grade production, purification, and characterization of diverse oncolytic viruses. Molecular Therapy\u2014Methods & Clinical Development, 3, 16018.","journal-title":"Molecular Therapy\u2014Methods & Clinical Development"},{"key":"616_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.seppur.2020.117503","volume":"254","author":"K Kawka","year":"2021","unstructured":"Kawka, K., Wilton, A. N., Madadkar, P., Medina, M. F. C., Lichty, B. D., Ghosh, R., & Latulippe, D. R. (2021). Integrated development of enzymatic DNA digestion and membrane chromatography processes for the purification of therapeutic adenoviruses. Separation and Purification Technology, 254, 117503.","journal-title":"Separation and Purification Technology"},{"key":"616_CR55","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1089\/bio.2011.0016","volume":"10","author":"W Shao","year":"2012","unstructured":"Shao, W., Khin, S., & Kopp, W. C. (2012). Characterization of effect of repeated freeze and thaw cycles on stability of genomic DNA using pulsed field gel electrophoresis. Biopreservation and Biobanking, 10, 4\u201311.","journal-title":"Biopreservation and Biobanking"},{"key":"616_CR56","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/734690","volume":"2011","author":"KH Chan","year":"2011","unstructured":"Chan, K. H., Peiris, J. S. M., Lam, S. Y., Poon, L. L. M., Yuen, K. Y., & Seto, W. H. (2011). The effects of temperature and relative humidity on the viability of the SARS coronavirus. Advances in Virology, 2011, 734690.","journal-title":"Advances in Virology"},{"key":"616_CR57","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1128\/JVI.79.1.581-591.2005","volume":"79","author":"SH Thorne","year":"2005","unstructured":"Thorne, S. H., Brooks, G., Lee, Y.-L., Au, T., Eng, L. F., & Reid, T. (2005). Effects of febrile temperature on adenoviral infection and replication: Implications for viral therapy of cancer. Journal of Virology, 79, 581\u2013591.","journal-title":"Journal of Virology"},{"key":"616_CR58","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1021\/bp025585a","volume":"19","author":"M Jardon","year":"2003","unstructured":"Jardon, M., & Garnier, A. (2003). pH, pCO2, and temperature effect on R-adenovirus production. Biotechnology Progress, 19, 202\u2013208.","journal-title":"Biotechnology Progress"},{"key":"616_CR59","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1089\/hgtb.2017.086","volume":"28","author":"AP Manceur","year":"2017","unstructured":"Manceur, A. P., Kim, H., Misic, V., Andreev, N., Dorion-Thibaudeau, J., Lanthier, S., Bernier, A., Tremblay, S., G\u00e9linas, A.-M., Broussau, S., Gilbert, R., & Ansorge, S. (2017). Scalable lentiviral vector production using stable HEK293SF producer cell lines. Human Gene Therapy Methods, 28, 330\u2013339.","journal-title":"Human Gene Therapy Methods"},{"key":"616_CR60","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.omtm.2018.10.008","volume":"11","author":"L Mekkaoui","year":"2018","unstructured":"Mekkaoui, L., Parekh, F., Kotsopoulou, E., Darling, D., Dickson, G., Cheung, G. W., Chan, L., MacLellan-Gibson, K., Mattiuzzo, G., Farzaneh, F., Takeuchi, Y., & Pule, M. (2018). Lentiviral vector purification using genetically encoded biotin mimic in packaging cell. Molecular Therapy Methods & Clinical Development, 11, 155\u2013165.","journal-title":"Molecular Therapy Methods & Clinical Development"},{"key":"616_CR61","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.memsci.2017.11.022","volume":"548","author":"S Shoaebargh","year":"2018","unstructured":"Shoaebargh, S., Gough, I., Medina, M. F., Smith, A., van der Heijden, J., Lichty, B. D., Bell, J. C., & Latulippe, D. R. (2018). Sterile filtration of oncolytic viruses: An analysis of effects of membrane morphology on fouling and product recovery. Journal of Membrane Science, 548, 239\u2013246.","journal-title":"Journal of Membrane Science"},{"key":"616_CR62","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.memsci.2008.08.046","volume":"325","author":"JX Zhou","year":"2008","unstructured":"Zhou, J. X., Qiu, J., Jiang, G., Zhou, C., Bingham, N., Yeung, H., Dransart, B., Wadhwa, M.-V., & Tressel, T. (2008). Non-specific binding and saturation of Polysorbate-20 with aseptic filter membranes for drug substance and drug product during mAb production. Journal of Membrane Science, 325, 735\u2013741.","journal-title":"Journal of Membrane Science"},{"key":"616_CR63","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/nar\/gkn020","volume":"36","author":"VK Coventry","year":"2008","unstructured":"Coventry, V. K., & Conn, G. L. (2008). Analysis of adenovirus VA RNA I structure and stability using compensatory base pair modifications. Nucleic Acids Research, 36, 1645\u20131653.","journal-title":"Nucleic Acids Research"},{"key":"616_CR64","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/jps.20496","volume":"95","author":"J Rexroad","year":"2006","unstructured":"Rexroad, J., Evans, R. K., & Middaugh, C. R. (2006). Effect of pH and ionic strength on the physical stability of adenovirus type 5. Journal of Pharmaceutical Sciences, 95, 237\u2013247.","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"616_CR65","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.cell.2015.07.058","volume":"162","author":"GA Shah","year":"2015","unstructured":"Shah, G. A., & O\u2019Shea, C. C. (2015). Viral and cellular genomes activate distinct DNA damage responses. Cell, 162, 987\u20131002.","journal-title":"Cell"},{"key":"616_CR66","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/gt.2010.167","volume":"18","author":"CL Halbert","year":"2011","unstructured":"Halbert, C. L., Metzger, M. J., Lam, S. L., & Miller, A. D. (2011). Capsid-expressing DNA in AAV vectors and its elimination by use of an oversize capsid gene for vector production. Gene Therapy, 18, 411\u2013417.","journal-title":"Gene Therapy"},{"key":"616_CR67","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/biotech10040022","volume":"10","author":"E Lerer","year":"2021","unstructured":"Lerer, E., Oren, Z., Kafri, Y., Adar, Y., Toister, E., Cherry, L., Lupu, E., Monash, A., Levy, R., Dor, E., Epstein, E., Levin, L., Girshengorn, M., Natan, N., Zichel, R., & Makovitzki, A. (2021). Highly efficient purification of recombinant VSV-\u2206G-spike vaccine against SARS-CoV-2 by flow-through chromatography. Biotech, 10, 22.","journal-title":"Biotech"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-022-00616-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-022-00616-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-022-00616-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T14:29:35Z","timestamp":1744208975000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-022-00616-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,30]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["616"],"URL":"https:\/\/doi.org\/10.1007\/s12033-022-00616-8","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,30]]},"assertion":[{"value":"25 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no commercial or financial conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Our study did not require an ethical board approval because it did not contain human or animal subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}